Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …

The rapid development of nanotechnology is opening a huge world of promising
possibilities in healthcare, but this is also increasing the necessity to study the potential risk …

Respiratory disease is a common disease with a high incidence worldwide, which is a
serious threat to human health, and is considered a societal and economic burden. The …

Environmentally persistent free radicals (EPFRs) are emerging pollutants that can adversely
affect human health. Although the pivotal roles of metal oxides in EPFR formation have been …

Microplastics (MPs) are ubiquitous environmental pollutants produced through the
degradation of plastic products. Nanoplastics (NPs), commonly coexisting with MPs in the …

Exposure of inhaled nanoparticles (NPs) to the deep lung tissue results in the adsorption of
pulmonary surfactant (PSf) on the surface of NPs and the formation of a biomolecular …

Lung cancer is one of the most common cancers, affecting more than 2.1 million people
across the globe every year. A very high occurrence and mortality rate of lung cancer have …

Many recent studies focus on the pulmonary delivery of vaccines as it is needle-free, safe,
and effective. Inhaled vaccines enhance systemic and mucosal immunization but still faces …

Inhalation of aerosolized compounds is a popular, non-invasive route for the targeted
delivery of therapeutic molecules to the lung. Various types of nanoparticles have been used …

Understanding the cellular uptake of nanomaterials (NMs) is a fundamental and critical
issue for uncovering biomedical effects of NMs and facilitating their practical applications in …